Health Care Technology
Company Overview of First Databank, Inc.
First Databank, Inc. offers integrated drug databases/knowledge and drug decision support tools. It offers National Drug Data File (NDDF) Plus, a drug database with medications approved by the FDA, which provides information on commonly-used over-the-counter (OTC) and alternative therapy agents; OrderView Med Orders Database that enables clinicians to use drug descriptions as search targets for completing med orders; International Drug Data File–Canada with information on prescription and OTC medications available in Canada; Multilex Drug Data File–Europe with clinical and commercial information; and FDB AlertSpace, an alert management solution to address alert fatigue in computerized provid...
701 Gateway Boulevard
South San Francisco, CA 94080
Founded in 1977
Key Executives for First Databank, Inc.
Chief Executive Officer and President
Vice President of Finance & Operations and General Manager of Indianapolis
President of Hearst Business Media
Vice President of Sales & Marketing and Customer Relations
Senior Vice President and Editorial Director
Compensation as of Fiscal Year 2013.
First Databank, Inc. Key Developments
First Databank Inc. Wins $3.3 Million Federal Contract
Jan 29 14
First Databank Inc. won a $3,304,807 federal contract from the U.S. Department of Veterans Affairs' Technology Acquisition Center, Eatontown, N.J., for drug database and decision support tools for pharmacy re-engineering.
First Databank Announces Release of the FDB High Risk Medication Module
Jul 24 13
First Databank announced the release of the FDB High Risk Medication Module(TM). The new drug knowledge enables FDB customers and other industry stakeholders to easily identify medications designated as high risk by the Food and Drug Administration (FDA) and have a Risk Evaluation and Mitigation Strategy (REMS) requirement. High risk medications can have serious life-threatening adverse effects but are approved by the FDA because the benefits of the drugs outweigh the risks for a specific condition. The FDA has put requirements in place to help ensure the safe use of high risk drugs with the use of boxed warnings and/or REMS, which are critical guidelines for clinicians and institutions that treat patients with these medications. Recognizing the complexity the industry faces in complying with REMS, the FDA is holding a two-day meeting on July 25-26 where stakeholders will describe issues and challenges associated with standardizing REMS requirements. One key opportunity being addressed at the meeting is how health information technologies such as electronic health records, pharmacy management systems and electronic prescribing systems could be used to integrate REMS into the health care delivery system. The FDB High Risk Medication Module is designed specifically to be used within these electronic healthcare systems. The FDB High Risk Medication Module also eliminates the manual and often tedious effort required to monitor REMS changes from drug manufacturers. Additionally, FDB keeps track of when changes are made to the requirements and maintains historical REMS information to support retrospective analysis or auditing.
First Databank, Inc. Releases Dosing Customization Capability in FDB AlertSpace(R) Alert Management Solution
Mar 1 13
First Databank, Inc. announced that medication dosing content is now available for customization in its alert management solution, FDB AlertSpace. The addition of this drug domain allows users to customize dose checking information, including dosing ranges, frequencies, units of measure and more. According to researchers, manually reducing the number of drug dosing alerts by individually modifying dose rule thresholds has been shown to improve alert acceptance rates. However, this process currently requires a considerable time investment by clinicians to determine which dosing rules should be corrected and to determine the proper alert thresholds. AlertSpace is intended to vastly simplify the process of editing alerts thereby reducing the required time investment. As part of the AlertSpace demonstration, FDB will be previewing the ONC drug-drug interaction (DDIs) subset, which will soon be incorporated into AlertSpace. This will enable users to identify a subset of high-priority alerts to activate and a set of lower-priority alerts that can be filtered.
Similar Private Companies By Industry
Recent Private Companies Transactions